PMGC Holdings (ELAB) Change in Cash (2022 - 2026)
PMGC Holdings (ELAB) posted Change in Cash of $9.0 million for Q1 2026, up 489.52% sequentially from -$2.3 million in Q4 2025, and up 548.71% YoY from $1.4 million in Q1 2025.
PMGC Holdings (ELAB) Change in Cash (2022 - 2026) Analysis & Trends
PMGC Holdings has reported Change in Cash for 5 years, with the latest figure at $9.0 million in Q1 2026.
- Quarterly Change in Cash rose 548.71% year-over-year to $9.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.0 million (up 103.36% YoY) and the FY2025 annual result came in at $1.4 million, up 115.61% from the prior year.
- Change in Cash advanced to $9.0 million in Q1 2026 per ELAB's latest filing, from -$2.3 million in the prior quarter.
- Over five years, Change in Cash peaked at $9.0 million in Q1 2026 and troughed at -$1.2 billion in Q4 2022.
- A 5-year average of -$81.9 million and a median of -$116733.0 in 2023 frame the typical range for Change in Cash.
- The widest YoY moves for Change in Cash: up 5184.51% in 2024, down 2085.17% in 2024.
- Over 5 years, Change in Cash stood at -$1.2 billion in 2022, then jumped by 100.25% to $2.8 million in 2023, then tumbled by 185.66% to -$2.4 million in 2024, then rose by 5.86% to -$2.3 million in 2025, then soared by 489.52% to $9.0 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered $9.0 million, -$2.3 million, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | PMGC Holdings | 31.22 Mn | 12.43 Mn | 385,691.00 | 3.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.95 Mn |
| Dec 31, 2025 | -2.30 Mn |
| Sep 30, 2025 | 2.02 Mn |
| Jun 30, 2025 | 318,194.00 |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | -2.44 Mn |
| Sep 30, 2024 | 6.33 Mn |
| Jun 30, 2024 | -843,763.00 |
| Mar 31, 2024 | -2.38 Mn |
| Dec 31, 2023 | 2.85 Mn |
| Sep 30, 2023 | -124,410.00 |
| Jun 30, 2023 | -444,580.00 |
| Mar 31, 2023 | -109,056.00 |
| Dec 31, 2022 | -1.16 Bn |